Found 62 matching trials
Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers PHASE1 This is a pilot, explorative, study to test the feasibility and safety of s...
Show More Location
Unit of Oncology - Ospedali Riuniti of Bergamo
Learn More & Join Trial
Affinity: Hospital Trial N/A Method comparison study to compare the Affinity prototype device using a ca...
Show More Location
The Christie NHS Foundation Trust
Learn More & Join Trial
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors NA Hepatic metastases are common in solid cancers (up to 30% of patients with ...
Show More Status
Active Not Recruiting
Location
Centre Georges François Leclerc
Learn More & Join Trial
Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation NA RATIONALE: Chemoprevention therapy is the use of certain drugs to try to pr...
Show More Location
CCOP - Scottsdale Oncology Program
Learn More & Join Trial
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma PHASE1 Phase I trial to study the effectiveness of irinotecan plus cyclosporine an...
Show More Location
University of Chicago Cancer Research Center
Learn More & Join Trial
Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors PHASE1 Phase I to determine safety of combining stereotactic body radiotherapy (SB...
Show More Status
Active Not Recruiting
Location
University of Chicago
Learn More & Join Trial
Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies PHASE2 This is a Phase II trial to evaluate the efficacy and safety of human leuko...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies N/A The primary objective of this protocol is to provide expanded access to tab...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors PHASE1 This phase I trial studies the side effects and the best dose of navitoclax...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
(COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies N/A Patients with cancer are considered vulnerable to severe acute respiratory ...
Show More Learn More & Join Trial